GREM2 and tuberculosis: The results show increased BMP2 gene expression levels and reduced expression levels of BMP2 antagonists, such as the GREM2 gene, in the TB-CM-treated MSCs, implicating the relevance of BMP2 signaling in regulating the osteogenesis of TB-CM-treated MSCs.